Table 5.
Molecules | PPB | Hepatotoxic | CYP2D6 | Solubility | BBB | IA |
---|---|---|---|---|---|---|
Hydroxychloroquine | false | true | true | 3 | 1 | 0 |
MolPort-009-219-532 | true | false | true | 2 | 0 | 0 |
MolPort-004-996-519 | true | false | false | 2 | 1 | 0 |
MolPort-005-060-605 | true | false | false | 2 | 1 | 0 |
MolPort-005-028-274 | true | false | false | 2 | 2 | 0 |
MolPort-004-042-669 | true | false | false | 2 | 2 | 0 |
MolPort-007-913-111 | false | false | false | 2 | 1 | 0 |
MolPort-002-693-933 | true | false | false | 2 | 1 | 0 |
MolPort-005-083-430 | true | false | true | 2 | 1 | 0 |
MolPort-009-499-144 | true | false | false | 2 | 2 | 0 |
BBB, blood–brain barrier (0 (Very high penetrant); 1 (High); 2 (Medium); 3 (Low); 4 (very low) [30]; Absorption, human intestinal absorption (acceptable range: range is 0–2, where 0 is a good absorption) [28]; Aqueous solubility, (acceptable range: range is 0–3, where 3 is a good solubility) [31]; Cytochrome P450 (CYP450) 2D6 inhibition (false—non-inhibitor, true—inhibitor) [28]; PPB, plasma–protein binding (false—does not bind to plasma proteins, true—binds to plasma proteins) [32,33]; Intestinal absorption (IA).